PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Trial shows alcohol-mimicking medication can give laryngeal dystonia patients back their voice

Sodium oxybate is the first oral treatment for laryngeal dystonia to show efficacy at providing temporary relief for debilitating symptoms that impact speaking, according to the results of a Mass Eye and Ear-led clinical trial

Trial shows alcohol-mimicking medication can give laryngeal dystonia patients back their voice
2024-11-20
(Press-News.org) KEY TAKEAWAYS

Researchers from Mass Eye and Ear conducted a clinical trial of sodium oxybate, an oral medication used to treat narcolepsy, for the treatment of laryngeal dystonia, an often-debilitating neurological condition that impacts speech. Trial was borne out of patient reports of symptom improvements after consuming alcohol.  A single dose of sodium oxybate significantly improved symptoms for alcohol-responsive patients, with effects lasting up to 5 hours.  The trial involved participants from across the U.S., U.K., and Canada and brings hope to the laryngeal dystonia community, who currently lack effective oral medications.  

Laryngeal dystonia (LD), a rare neurological disease that significantly impacts a person’s ability to speak due to uncontrollable vocal cord spasms, can have a debilitating effect on a person’s social life, employment and mental health. Currently, LD is most commonly managed with botulinum neurotoxin (Botox) injections, but this treatment is ineffective for up to 40% of patients who receive it. Now, a study led by researchers from Mass Eye and Ear, a member of the Mass General Brigham healthcare system, shows that an oral medication, sodium oxybate, is more effective than placebo at reducing LD symptoms in patients whose symptoms improve when they consume alcohol.

The results from the phase 2b randomized clinical trial, published November 20th in Annals of Neurology, build on more than a decade of research spurred by anecdotal reports from patients with LD who said their symptoms improved after consuming a couple alcoholic drinks. Sodium oxybate is a central nervous system agent that is FDA-approved to treat patients with narcolepsy and sleep disorders. Sodium oxybate mimics some of the effects of alcohol.

In the trial of more than 100 patients, a single dose of sodium oxybate significantly improved symptoms of patients with alcohol-responsive LD without causing serious side effects. The minimum efficacy of the drug was 16% of voice improvement, with the average of 41% in patients with alcohol-responsive LD. Sodium oxybate showed no significant changes from placebo in LD patients whose symptoms do not improve with alcohol.

“We hear many stories of broken lives and careers from patients with laryngeal dystonia and they have been desperate for new treatments. Our trial gives us hope for a new, effective treatment that can be offered to some of these patients,” says lead author Kristina Simonyan, MD, PhD, Dr med, vice chair for clinical research in the Department of Otolaryngology-Head and Neck Surgery at Mass Eye and Ear and professor of Otolaryngology-Head and Neck Surgery at Harvard Medical School. “There's a lot of interest from the dystonia community, and we get many calls from patients asking, ‘When will this drug be available? How can I have a prescription?’”

Laryngeal dystonia, known previously as spasmodic dysphonia, is a rare condition that affects over 50,000 people in the US and Canada. It is more common in women than men and typically onsets in 40s, often taking a significant toll on their quality of life. Its exact neurological cause is unknown, and patients on average take up to 5.5 years to receive a correct diagnosis. Once diagnosed, treatment options are limited to Botox injections every three-to-four months for life, if effective.     

In previous open label trials, Simonyan’s team showed that sodium oxybate improves voice symptoms in 82% of patients with alcohol-responsive LD. In their new study, the team wanted to confirm the drug’s efficacy in a more rigorous comparison against a placebo using a double-blind randomized clinical trial design.

The investigators enrolled 106 participants with LD, 50 of whom had alcohol-responsive symptoms. Alcohol responsiveness was determined by a standardized alcohol challenge test using a controlled amount of vodka. Participants traveled from across the U.S., the U.K. and Canada to participate in the trial—testimony to the excitement that this drug offers to the dystonia community. Over the course of two days, each patient received single doses of 1.5g of sodium oxybate or placebo that was matched by its taste, smell, color, and appearance to the drug. The trial was conducted in a double-blind fashion, meaning that neither patient nor clinician knew when they received the active drug. To test the treatment’s effectiveness, the team assessed the patients’ voice symptoms before the treatment and different intervals after the treatment.

Sodium oxybate was significantly more effective at reducing symptoms than placebo for patients with alcohol-responsive LD but not those whose symptoms do not improve with alcohol. The efficacy of sodium oxybate in alcohol-responsive LD did not differ between patients with various symptom severity (mild to severe) or those who had additional voice symptoms, such as voice tremor.

Voice symptoms in alcohol-responsive LD patients significantly improved about 40 minutes after drug intake, with the benefits lasting up to 5 hours. Though some patients experienced mild and transient side effects such as nausea, dizziness and daytime sleepiness, there were no serious adverse events and no rebound in symptom severity after the drug wore off.

“Our findings suggest that sodium oxybate can be taken on an as-needed basis, such as before work or a social event, so patients can tailor treatment to their own daily needs and get in control of their symptoms,” said Simonyan.

Looking ahead, Simonyan’s team is planning to conduct a phase 3 multi-site randomized clinical trial to further assess the drug’s efficacy and safety in LD patients. Her lab is also leading studies using artificial intelligence to determine which patients might benefit from the treatment as well as alternative treatments for LD patients whose symptoms are not responsive to alcohol.

Authorship: In addition to Simonyan, study co-authors include Lena C. O’Flynn (MEE), Azadeh Hamzehei Sichani, MA (MEE), Steven J. Frucht, MD (NYU), Anna F. Rumbach, PhD (Queensland), Nutan Sharma, MD, PhD (MGH), Phillip C. Song, MD (MEE) and Alexis Worthley (MEE).

Disclosures: The authors report no conflicts of interest.

Funding: This study was funded by the National Institute on Deafness and Other Communication Disorders of the National Institutes of Health, grant R01DC012545.

Paper cited: Simonyan, K et al. “Efficacy and Safety of Sodium Oxybate in Isolated Focal Laryngeal Dystonia: A Phase IIb Double-Blind Placebo-Controlled Cross-Over Randomized Clinical Trial” Annals of Neurology DOI:10.1002/ana.27121

###

About Mass Eye and Ear

Massachusetts Eye and Ear, founded in 1824, is an international center for treatment and research and a teaching hospital of Harvard Medical School. A member of Mass General Brigham, Mass Eye and Ear specializes in ophthalmology (eye care) and otolaryngology–head and neck surgery (ear, nose and throat care). Mass Eye and Ear clinicians provide care ranging from the routine to the very complex. Also home to the world's largest community of hearing and vision researchers, Mass Eye and Ear scientists are driven by a mission to discover the basic biology underlying conditions affecting the eyes, ears, nose, throat, head and neck and to develop new treatments and cures. In the 2024–2025 “Best Hospitals Survey,” U.S. News & World Report ranked Mass Eye and Ear #4 in the nation for eye care and #6 for ear, nose and throat care. For more information about life-changing care and research at Mass Eye and Ear, visit our blog, Focus, and follow us on Instagram, Twitter and Facebook. 

END


[Attachments] See images for this press release:
Trial shows alcohol-mimicking medication can give laryngeal dystonia patients back their voice Trial shows alcohol-mimicking medication can give laryngeal dystonia patients back their voice 2

ELSE PRESS RELEASES FROM THIS DATE:

Cigarette smoke alters microbiota, aggravates flu severity

2024-11-20
Highlights: Cigarette smoke exposure is associated with many different respiratory diseases. A new study shows that cigarette smoke alters the microbial community in the gut and the oropharynx. The study shows that the cigarette-smoke induced changes to the microbiota resulted in increased severity of disease in mice infected with influenza A virus. Washington, D.C.—New research has shown that cigarette smoke can induce disordered oropharyngeal microbiota that aggravates the severity of influenza A ...

Landmark study reveals over 100,000 American youth living with inflammatory bowel disease

2024-11-20
Embargoed until Wednesday, Nov. 20 @ 9AM ET   New York, NY - November 20, 2024 - A groundbreaking study published today in Gastroenterology provides the most comprehensive assessment to date of pediatric inflammatory bowel disease (IBD) prevalence in the United States. Funded by the Centers for Disease Control and Prevention (CDC), the research, led by investigators from the Crohn’s & Colitis Foundation, University of North Carolina at Chapel Hill, and the University of Pennsylvania, estimates that more than 100,000 American youth under the age of 20 live with IBD. The study illustrates ...

Diverse diets of civets in Borneo rainforest allow them to live in same geographical area

Diverse diets of civets in Borneo rainforest allow them to live in same geographical area
2024-11-20
Four closely related civets, a small nocturnal animal found in Africa and Asia, have made the same geographical area in the rainforests of Borneo home. Typically, closely related animal species have difficulty coexisting because they are competing for the same or similar resources. Despite eating the same figs, binturong, small-toothed palm, masked palm, and common palm civets do coexist together. To understand how they coexist, researchers used a compound-specific nitrogen isotope analysis to understand the degree of faunivory (eating animals). The results ...

Virtual reality could be gamechanger in police-civilian crisis encounters

Virtual reality could be gamechanger in police-civilian crisis encounters
2024-11-20
Mental illness significantly increases the risk of arrest during police encounters, with 25% of those with mental health conditions reporting arrest histories. Studies reveal frequent use of excessive force and 25% of fatal police encounters involve individuals with mental illness. Traditional police training offers limited opportunities for officers to practice handling complex civilian interactions, especially with individuals experiencing mental health crises. This lack of hands-on experience leaves officers ill-prepared to navigate these situations with the necessary empathy and de-escalation ...

Recycled pacemakers function as well as new devices, international study suggests

2024-11-20
Recycled pacemakers can function as well as new devices, a University of Michigan-led study suggests.  These used and reconditioned devices have the potential to increase access to pacemaker therapy in low- and middle-income countries, where many patients cannot afford the treatment. Researchers from the U-M Health Frankel Cardiovascular Center reported the findings as a late-breaking abstract at the 2024 American Heart Association Scientific Sessions. The international clinical trial involved nearly 300 people across seven ...

Researchers eliminate the gritty mouth feel: How to make it easier to eat fiber-rich foods

Researchers eliminate the gritty mouth feel: How to make it easier to eat fiber-rich foods
2024-11-20
Fiber is something that most of us get far too little of. To change that, we need to actually enjoy eating it. Food researchers from the University of Copenhagen have now invented a "disguise" that solves the problem of the dry and gritty mouth feel of fibers. Think of how it would be to drink a juice with wheat bran in it – you may imagine an unpleasant gritty sensation which would make you less prone to enjoy it. Unfortunately, this feeling is often associated with insoluble dietary fibers. ...

An innovative antibiotic for drug-resistant bacteria

2024-11-20
Antibacterial drugs are important for treating infections. But increasingly, bacterial resistance to current drugs — so they don’t work well, or even at all — means new ones are urgently needed. Building on previous work, researchers in ACS Infectious Diseases have demonstrated a potential antibacterial treatment from a modified darobactin, a compound originally from a bacterium. The team reports proof-of-concept animal trials on infections caused by bacteria, including E. coli, that are known to develop drug resistance. This study was published during the World Health Organization’s World Antimicrobial Resistance (AMR) Awareness ...

Garden produce grown near Fayetteville works fluorochemical plant contains GenX, other PFAs

2024-11-20
Residential garden produce grown near the Fayetteville Works fluorochemical plant can expose those who consume it to per- and polyfluoroalkyl substances (PFAS), according to a new study conducted by researchers from North Carolina State University, East Carolina University and the Colorado School of Mines. “It is often assumed that contaminated drinking water is the main pathway through which we are exposed to PFAS,” says Detlef Knappe, professor of civil, construction, and environmental engineering at NC State and a lead investigator of the study. “An important goal of our study was to determine whether people ...

CMU-Africa expands digital public infrastructure initiative across the continent

2024-11-20
Carnegie Mellon University Africa announced today that it will expand its digital public infrastructure initiative across the continent. Called the Upanzi Network, this Africa-based collaboration of engineering research labs will work toward a secure and resilient digital transformation by focusing on innovation across the entire pipeline of open standard technologies for the public good. The initiative was launched in 2021 with the creation of a research laboratory at CMU-Africa in Kigali, Rwanda. Since its launch, the laboratory has made progress in capacity building, knowledge transfer, and digital public infrastructure governance and deployment. It performs research in ...

Study calls for city fashion waste shakeup

Study calls for city fashion waste shakeup
2024-11-20
With most donated clothes exported or thrown away, experts are calling for a shakeup of how we deal with the growing fashion waste issue. A first of its kind study, published in Nature Cities, analysed what happens to clothes and other textiles after consumers no longer want them in Amsterdam, Austin, Berlin, Geneva, Luxembourg, Manchester, Melbourne, Oslo and Toronto. Across most western cities from Melbourne to Manchester it found the same pattern of textile waste being exported, going to landfill or being dumped in the environment. Global textiles waste each year weighs 92 million tonnes and this could double by 2030. Charity shops handle a large amount of used clothes, but the study ...

LAST 30 PRESS RELEASES:

Scientists unlock secrets behind flowering of the king of fruits

Texas A&M researchers illuminate the mysteries of icy ocean worlds

Prosthetic material could help reduce infections from intravenous catheters

Can the heart heal itself? New study says it can

Microscopic discovery in cancer cells could have a big impact

Rice researchers take ‘significant leap forward’ with quantum simulation of molecular electron transfer

Breakthrough new material brings affordable, sustainable future within grasp

How everyday activities inside your home can generate energy

Inequality weakens local governance and public satisfaction, study finds

Uncovering key molecular factors behind malaria’s deadliest strain

UC Davis researchers help decode the cause of aggressive breast cancer in women of color

Researchers discovered replication hubs for human norovirus

SNU researchers develop the world’s most sensitive flexible strain sensor

Tiny, wireless antennas use light to monitor cellular communication

Neutrality has played a pivotal, but under-examined, role in international relations, new research shows

Study reveals right whales live 130 years — or more

Researchers reveal how human eyelashes promote water drainage

Pollinators most vulnerable to rising global temperatures are flies, study shows

DFG to fund eight new research units

Modern AI systems have achieved Turing's vision, but not exactly how he hoped

Quantum walk computing unlocks new potential in quantum science and technology

Construction materials and household items are a part of a long-term carbon sink called the “technosphere”

First demonstration of quantum teleportation over busy Internet cables

Disparities and gaps in breast cancer screening for women ages 40 to 49

US tobacco 21 policies and potential mortality reductions by state

AI-driven approach reveals hidden hazards of chemical mixtures in rivers

Older age linked to increased complications after breast reconstruction

ESA and NASA satellites deliver first joint picture of Greenland Ice Sheet melting

Early detection model for pancreatic necrosis improves patient outcomes

Poor vascular health accelerates brain ageing

[Press-News.org] Trial shows alcohol-mimicking medication can give laryngeal dystonia patients back their voice
Sodium oxybate is the first oral treatment for laryngeal dystonia to show efficacy at providing temporary relief for debilitating symptoms that impact speaking, according to the results of a Mass Eye and Ear-led clinical trial